[HTML][HTML] Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks

CF Estivariz, SD Kovacs, O Mach - Vaccine, 2023 - Elsevier
Delivering inactivated poliovirus vaccine (IPV) with oral poliovirus vaccine (OPV) in
campaigns has been explored to accelerate the control of type 2 circulating vaccine-derived …

[HTML][HTML] Evaluation of vaccine derived poliovirus type 2 outbreak response options: a randomized controlled trial, Karachi, Pakistan

AF Saleem, MT Yousafzai, O Mach, A Khan, F Quadri… - Vaccine, 2018 - Elsevier
Background Outbreaks of circulating vaccine derived polioviruses type 2 (cVDPV2) remain a
risk to poliovirus eradication in an era without live poliovirus vaccine containing type 2 in …

[HTML][HTML] Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States

M Marin - MMWR. Morbidity and Mortality Weekly Report, 2017 - cdc.gov
In 1988, the World Health Assembly resolved to eradicate poliomyelitis (polio). Since then,
wild poliovirus (WPV) cases have declined by> 99.9%, from an estimated 350,000 cases of …

[HTML][HTML] Update on vaccine-derived polioviruses—worldwide, January 2017–June 2018

J Jorba - MMWR. Morbidity and Mortality Weekly Report, 2018 - cdc.gov
After the 2016 synchronized switch from trivalent oral poliovirus vaccine (OPV)(types 1, 2,
and 3) to bivalent OPV (types 1 and 3), transmission of type 2 circulating VDPVs (cVDPVs) …

Evolution of inactivated poliovirus vaccine use for the endgame and beyond

AS Bandyopadhyay… - The Journal of Infectious …, 2020 - academic.oup.com
More than 6 decades after licensure of inactivated poliovirus vaccine (IPV) as the first polio
vaccine, optimal use of IPV for polio prevention continues to be an area of interest. With the …

[HTML][HTML] Estimated effect of inactivated poliovirus vaccine campaigns, Nigeria and Pakistan, January 2014–April 2016

G Shirreff, MZ Wadood, RG Vaz, RW Sutter… - Emerging Infectious …, 2017 - ncbi.nlm.nih.gov
In 2014, inactivated poliovirus vaccine (IPV) campaigns were implemented in Nigeria and
Pakistan after clinical trials showed that IPV boosts intestinal immunity in children previously …

[HTML][HTML] Outbreak response strategies with type 2-containing oral poliovirus vaccines

DA Kalkowska, SGF Wassilak, MA Pallansch… - Vaccine, 2023 - Elsevier
Despite exhaustive and fully-financed plans to manage the risks of globally coordinated
cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of …

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with …

LV Cooper, AS Bandyopadhyay, N Gumede… - The Lancet Infectious …, 2022 - thelancet.com
Background Expanding outbreaks of circulating vaccine-derived type 2 poliovirus (cVDPV2)
across Africa after the global withdrawal of trivalent oral poliovirus vaccine (OPV) in 2016 …

Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge

TR Hird, NC Grassly - PLoS pathogens, 2012 - journals.plos.org
Inactivated poliovirus vaccine (IPV) may be used in mass vaccination campaigns during the
final stages of polio eradication. It is also likely to be adopted by many countries following …

Outbreak management strategies for cocirculation of multiple poliovirus types

DA Kalkowska, K Badizadegan, KM Thompson - Vaccine, 2023 - Elsevier
Prior modeling studies showed that current outbreak management strategies are unlikely to
stop outbreaks caused by type 1 wild polioviruses (WPV1) or circulating vaccine-derived …